About: Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.33 (+0.15%)
Status: deslistada — removed_from_provider. Este ativo não é mais negociado; são exibidos dados históricos.
ANEB NASDAQ Anebulo Pharmaceuticals Inc
Anebulo Pharmaceuticals Inc share price
Atividade de preço de ANEB
Último preço
Variação (24h)
USD
Volume
-
Volume (média 4 sem.)
-
Fechamento anterior
N/D
Último negócio
ANEB price performance
quote.marketSignals